BeOne Medicines Ltd. — Director's Dealing 2018

Aug 31, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BeiGene, Ltd. (BGNE)
CIK: 0001651308
Period of Report: 2018-08-29

Reporting Person: Glazer Donald W. (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-08-29	American Depositary Shares	S	1000	$179	Disposed	14384	Direct
2018-08-30	American Depositary Shares	S	1000	$179	Disposed	13384	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Ordinary Shares	4136940	Direct
Ordinary Shares	38160	Indirect

Footnotes

F1: Each American Depositary Share represents 13 Ordinary Shares.